Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;177(1):30-7.
doi: 10.1111/cei.12321.

The intestinal microbiome in type 1 diabetes

J L Dunne  1 , E W Triplett, D Gevers, R Xavier, R Insel, J Danska, M A Atkinson
Affiliations
Review

The intestinal microbiome in type 1 diabetes

J L Dunne et al. Clin Exp Immunol. 2014 Jul.

Abstract

Few concepts in recent years have garnered more disease research attention than that of the intestinal (i.e. 'gut') microbiome. This emerging interest has included investigations of the microbiome's role in the pathogenesis of a variety of autoimmune disorders, including type 1 diabetes (T1D). Indeed, a growing number of recent studies of patients with T1D or at varying levels of risk for this disease, as well as in animal models of the disorder, lend increasing support to the notion that alterations in the microbiome precede T1D onset. Herein, we review these investigations, examining the mechanisms by which the microbiome may influence T1D development and explore how multi-disciplinary analysis of the microbiome and the host immune response may provide novel biomarkers and therapeutic options for prevention of T1D.

Keywords: autoimmunity; immunology; insulin; intestinal physiology; microbiome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
‘The perfect storm’ – a hypothetical model of the contribution of various gut components (including altered immune regulation and gut leakiness) to the pathogenesis of type 1 diabetes. Reproduced with permission .
See this image and copyright information in PMC

References

    1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–229. - PubMed
    1. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2013;383:69–82. - PMC - PubMed
    1. Bodansky HJ, Staines A, Stephenson C, Haigh D, Cartwright R. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ. 1992;304:1020–1022. - PMC - PubMed
    1. Gillespie KM, Bain SC, Barnett AH, et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet. 2004;364:1699–1700. - PubMed
    1. Klemetti P, Savilahti E, Ilonen J, Akerblom HK, Vaarala O. T-cell reactivity to wheat gluten in patients with insulin-dependent diabetes mellitus. Scand J Immunol. 1998;47:48–53. - PubMed